In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia

Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait

(2013) Faten Al-Wathiqi et al.   BMC INFECTIOUS DISEASES

Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis

(2013) Seyedmojtaba Seyedmousavi et al.   Expert Review of Anti-Infective Therapy

Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)

(2013) I. Jarque et al.   MEDICAL MYCOLOGY

A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients

(2012) Stijn I. Blot et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Invasive Fungal Infections in Patients with Hematologic Malignancies (Aurora Project): Lights and Shadows During 18-Months Surveillance

(2012) Maria Teresa Montagna et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Invasive Aspergillosis: Resistance to Antifungal Drugs

(2012) Inès Hadrich et al.   MYCOPATHOLOGIA

Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment

(2011) Michael A. Pfaller   AMERICAN JOURNAL OF MEDICINE

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Caspofungin and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

(2011) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cryptic Species and Azole Resistance in the Aspergillus niger Complex

(2011) Susan J. Howard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

(2011) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Transcriptional Regulation of Chitin Synthases by Calcineurin Controls Paradoxical Growth of Aspergillus fumigatus in Response to Caspofungin

(2010) J. R. Fortwendel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Aspergillus Species to the Triazoles

(2010) M. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Species Identification and Antifungal Susceptibility Patterns of Species Belonging to Aspergillus Section Nigri

(2009) L. Alcazar-Fuoli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network

(2009) J. W. Baddley et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Aspergillus flavus: an emerging non-fumigatus Aspergillusspecies of significance

(2009) Suganthini Krishnan et al.   MYCOSES

Associations antifongiques dans les infections fongiques invasives

(2009) J. Gellen-Dautremer et al.   REVUE DE MEDECINE INTERNE

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY